We use cookies to improve security, personalize the user experience, enhance our marketing activities (including cooperating with our marketing partners) and for other business use.
Click "here" to read our Cookie Policy. By clicking "Accept" you agree to the use of cookies. Read less
Read more
Accept
Loading
Form preview
  • US Legal Forms
  • Form Library
  • More Forms
  • More Uncategorized Forms
  • Dimesylate C- Ii Rx Only - Accessdata Fda

Get Dimesylate C- Ii Rx Only - Accessdata Fda

VyvanseTM ( dimesylate) C II Rx Only AMPHETAMINES HAVE A HIGH POTENTIAL FOR ABUSE. ADMINISTRATION OF AMPHETAMINES FOR PROLONGED PERIODS OF TIME MAY LEAD TO DRUG DEPENDENCE. PARTICULAR.

How it works

  1. Open form

    Open form follow the instructions

  2. Easily sign form

    Easily sign the form with your finger

  3. Share form

    Send filled & signed form or save

How to fill out the Dimesylate C- II Rx Only - Accessdata Fda online

This guide provides clear, step-by-step instructions for filling out the Dimesylate C- II Rx Only form online. Adhering to these guidelines will ensure accuracy and efficiency in your submission.

Follow the steps to accurately complete the form.

  1. Press the ‘Get Form’ button to retrieve the document and open it in your online editor.
  2. Begin filling out the patient information section. Provide accurate details including the patient's full name, date of birth, and address. Make sure the information matches all identification documents.
  3. In the medication section, clearly specify the name of the medication as 'Dimesylate', including the strength and dosage instructions as directed by the healthcare provider.
  4. Fill in the prescriber’s details, ensuring that you input their full name, contact information, and their prescribing credentials accurately.
  5. Complete the signature section. The prescriber must sign and date the form, indicating the legitimacy of the prescription.
  6. Review all entered information for accuracy to prevent errors. Double-check that all fields are filled out completely.
  7. After confirming the information is correct, you can save your changes. Options to download, print, or share the completed form will be available based on the editor's functionality.

Complete your documents online today for a smoother management process.

Get form

Experience a faster way to fill out and sign forms on the web. Access the most extensive library of templates available.
Get form

Related content

- FDA
. TM. ( dimesylate). C- II Rx Only. AMPHETAMINES HAVE A HIGH POTENTIAL FOR ABUSE...
Learn more
Reference ID: 2862260 - FDA
® ( dimesylate) Capsules, CII ... 1088 or www.fda.gov/medwatch ... Pregnancy: Use only if...
Learn more
Amfetamin juga telah terbukti masuk ke dalam ASI, jadi IPCS dan USFDA menyarankan para ibu...
Learn more

Related links form

SSA-16-BK 2015 CA BACB Experience Standards 2017 SSA-787 2010 Hud 2350

Questions & Answers

Get answers to your most pressing questions about US Legal Forms API.

Contact support

, sold under the brand name among others, is a stimulant medication that is mainly used to treat attention deficit hyperactivity disorder (ADHD) in people over the age of five as well as moderate-to-severe binge eating disorder in adults.

The Biopharmaceutics Classification System (BCS) Class of the drug substance was not identified; however, the solubility and permeability2 are consistent with BCS Class 3. The literature2 states that the drug has a solubility of 792 mg/mL in water.

On January 30, 2015, dimesylate (; Shire), an oral central nervous system (CNS) stimulant, became the first medication to be approved by the FDA for the treatment of adults with binge-eating disorder.

Approval Date: 02/23/2007.

dimesylate is used to treat attention deficit hyperactivity disorder (ADHD) in adults and children 6 years of age and older. This medicine is also used to treat moderate to severe binge eating disorder (BED). It belongs to the group of medicines called central nervous system (CNS) stimulants.

The recommended starting dose is 30 mg/day to be titrated in increments of 20 mg at approximately weekly intervals to achieve the recommended target dose of 50 to 70 mg/day. The maximum dose is 70 mg/day [see Clinical Studies (14.2)]. Discontinue if binge eating does not improve.

® is indicated for the treatment of: Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies (14.1)] Moderate to Severe Binge Eating Disorder (BED) in adults [see Clinical Studies (14.2)]. Limitation of Use: is not indicated or recommended for weight loss.

Overusing may also cause sudden death or serious heart problems, such as heart attack or stroke. Tell your doctor if you or anyone in your family drinks or has ever drunk large amounts of alcohol, uses or has ever used street drugs, or has overused prescription medications.

Get This Form Now!

Use professional pre-built templates to fill in and sign documents online faster. Get access to thousands of forms.
Get form
If you believe that this page should be taken down, please follow our DMCA take down processhere.

Industry-leading security and compliance

US Legal Forms protects your data by complying with industry-specific security standards.
  • In businnes since 1997
    25+ years providing professional legal documents.
  • Accredited business
    Guarantees that a business meets BBB accreditation standards in the US and Canada.
  • Secured by Braintree
    Validated Level 1 PCI DSS compliant payment gateway that accepts most major credit and debit card brands from across the globe.
Get Dimesylate C- II Rx Only - Accessdata Fda
Get form
Form Packages
Adoption
Bankruptcy
Contractors
Divorce
Home Sales
Employment
Identity Theft
Incorporation
Landlord Tenant
Living Trust
Name Change
Personal Planning
Small Business
Wills & Estates
Packages A-Z
Form Categories
Affidavits
Bankruptcy
Bill of Sale
Corporate - LLC
Divorce
Employment
Identity Theft
Internet Technology
Landlord Tenant
Living Wills
Name Change
Power of Attorney
Real Estate
Small Estates
Wills
All Forms
Forms A-Z
Form Library
Customer Service
Terms of Service
Privacy Notice
Legal Hub
Content Takedown Policy
Bug Bounty Program
About Us
Blog
Affiliates
Contact Us
Delete My Account
Site Map
Industries
Forms in Spanish
Localized Forms
State-specific Forms
Forms Kit
Legal Guides
Real Estate Handbook
All Guides
Prepared for You
Notarize
Incorporation services
Our Customers
For Consumers
For Small Business
For Attorneys
Our Sites
US Legal Forms
USLegal
FormsPass
pdfFiller
signNow
airSlate WorkFlow
DocHub
Instapage
Social Media
Call us now toll free:
+1 833 426 79 33
As seen in:
  • USA Today logo picture
  • CBC News logo picture
  • LA Times logo picture
  • The Washington Post logo picture
  • AP logo picture
  • Forbes logo picture
© Copyright 1997-2025
airSlate Legal Forms, Inc.
3720 Flowood Dr, Flowood, Mississippi 39232
Form Packages
Adoption
Bankruptcy
Contractors
Divorce
Home Sales
Employment
Identity Theft
Incorporation
Landlord Tenant
Living Trust
Name Change
Personal Planning
Small Business
Wills & Estates
Packages A-Z
Form Categories
Affidavits
Bankruptcy
Bill of Sale
Corporate - LLC
Divorce
Employment
Identity Theft
Internet Technology
Landlord Tenant
Living Wills
Name Change
Power of Attorney
Real Estate
Small Estates
Wills
All Forms
Forms A-Z
Form Library
Customer Service
Terms of Service
Privacy Notice
Legal Hub
Content Takedown Policy
Bug Bounty Program
About Us
Blog
Affiliates
Contact Us
Delete My Account
Site Map
Industries
Forms in Spanish
Localized Forms
State-specific Forms
Forms Kit
Legal Guides
Real Estate Handbook
All Guides
Prepared for You
Notarize
Incorporation services
Our Customers
For Consumers
For Small Business
For Attorneys
Our Sites
US Legal Forms
USLegal
FormsPass
pdfFiller
signNow
airSlate WorkFlow
DocHub
Instapage
Social Media
Call us now toll free:
+1 833 426 79 33
As seen in:
  • USA Today logo picture
  • CBC News logo picture
  • LA Times logo picture
  • The Washington Post logo picture
  • AP logo picture
  • Forbes logo picture
© Copyright 1997-2025
airSlate Legal Forms, Inc.
3720 Flowood Dr, Flowood, Mississippi 39232